Literature DB >> 30069857

Colitis and Pancreatitis in a Patient with Systemic Lupus Erythematosus: Due to Disease or to Drug?

Swathi Paleti1, Bharath Yarlagadda2, Anas Gremida3, Muhammad Aziz2, Joshua Hanson4, Denis McCarthy3.   

Abstract

Entities:  

Keywords:  Apoptosis; Atrophy; Cellcept®; Colitis; Crypt distortion; Diarrhea; Immunosuppression; Lupoid nephritis; Mycophenolate; Mycophenolic acid; Myfortic®; Pancreatitis systemic lupus erythematosus

Mesh：

Substances：

Year:  2018        PMID： 30069857     DOI： 10.1007/s10620-018-5225-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  28 in total

1.  Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis.

Authors:  George Liapis; John Boletis; Chrysanthi Skalioti; George Bamias; Katerina Tsimaratou; Efstratios Patsouris; Ioanna Delladetsima
Journal:  Histopathology       Date:  2013-09-11       Impact factor: 5.087

2.  Acute pancreatitis in paediatric systemic lupus erythematosus.

Authors:  Laurence Perrin; Irina Giurgea; Valérie Baudet-Bonneville; Georges Deschênes; Albert Bensman; Tim Ulinski
Journal:  Acta Paediatr       Date:  2006-01       Impact factor: 2.299

3.  Lupus enteritis detected by capsule endoscopy.

Authors:  Hiroki Endo; Yasuyuki Kondo; Kei Kawagoe; Tomohiko R Ohya; Tatsuro Yanagawa; Masako Asayama; Kantaro Hisatomi; Takuma Teratani; Masato Yoneda; Masahiko Inamori; Atsushi Nakajima; Nobuyuki Matsuhashi
Journal:  Intern Med       Date:  2007-09-14       Impact factor: 1.271

4.  Clinicopathologic features and outcome of mycophenolate-induced colitis in renal transplant recipients.

Authors:  Luis Gustavo M de Andrade; Maria Aparecida M Rodrigues; Fernando G Romeiro; Paula D Garcia; Mariana M Contti; Maria Fernanda C de Carvalho
Journal:  Clin Transplant       Date:  2014-09-16       Impact factor: 2.863

Review 5.  Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.

Authors:  Anthony C Allison; Elsie M Eugui
Journal:  Transplantation       Date:  2005-10-15       Impact factor: 4.939

Review 6.  Mycophenolate mofetil in the treatment of systemic lupus erythematosus.

Authors:  Maria Dall'Era
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

7.  Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital.

Authors:  T Y Lian; C J Edwards; S P Chan; H H Chng
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 8.  Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.

Authors:  D O Taylor; R D Ensley; S L Olsen; D Dunn; D G Renlund
Journal:  J Heart Lung Transplant       Date:  1994 Jul-Aug       Impact factor: 10.247

9.  Fatal acute pancreatitis complicated by pancreatic pseudocysts in a patient with systemic lupus erythematosus.

Authors:  Ernesto Cairoli; Gerardo Pérez; Arturo Briva; Mario Cancela; Juan Alonso
Journal:  Rheumatol Int       Date:  2009-05-23       Impact factor: 2.631

Review 10.  Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis.

Authors:  R Andrew Moore; Sheena Derry
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.